Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Property, Plant & Equipment (Net) (2022 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Property, Plant & Equipment (Net) of $1.21 million in the quarter ended Jun 30, 2026, up 84.9% from $655,578 a year earlier and up 4.4% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends

As of Dec 31, 2025, Eupraxia Pharmaceuticals reported Property, Plant & Equipment (Net) of $834,429, up 133.2% from the prior year.

  • Annual Property, Plant & Equipment (Net) has a three-year compound annual growth rate of 23.5% (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Property, Plant & Equipment (Net) came in at $357,893 in the year ended Dec 31, 2024 (-12.6%), $409,587 in the year ended Dec 31, 2023 (-7.6%) and $443,464 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Property, Plant & Equipment (Net) in data going back to the quarter ended Dec 31, 2022.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has increased for six consecutive quarters, with growth averaging 77.5% over the last seven quarters.
  • Peak year-over-year performance for Property, Plant & Equipment (Net) in the last five years was growth of 133.6% in the quarter ended Mar 31, 2026, against a decline of 12.6% in the quarter ended Dec 31, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.16 million (quarter ended Mar 31, 2026), $834,429 (quarter ended Dec 31, 2025) and $682,835 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Eupraxia Pharmaceuticals 289.28 Mn 287.68 Mn - 1.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.21 Mn
Mar 31, 2026 1.16 Mn
Dec 31, 2025 834,429.00
Sep 30, 2025 682,835.00
Jun 30, 2025 655,578.00
Mar 31, 2025 497,282.00
Dec 31, 2024 357,893.00
Sep 30, 2024 370,004.00
Jun 30, 2024 347,422.00
Mar 31, 2024 381,731.00
Dec 31, 2023 409,587.00
Dec 31, 2022 443,464.00
API Access

Eupraxia Pharmaceuticals Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=EPRX&period=max&api_key=YOUR_API_KEY